Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000568311

Apexbio Technology LLC Anti-IL-23a-Ab-Risankizumab
SDP

Catalog No. 5000568311
Encompass_Preferred

Anti-IL-23a Antibody (Risankizumab) (CAS No 1612838-76-2) is a monoclonal antibody primarily used in immunology research It targets the p19 subunit of interleukin-23 (IL-23) a cytokine involved in inflammatory pathways pivotal to autoimmune conditions like psoriasis By inhibiting IL-23 Risankizumab modulates the signaling pathway that influences Th17 cell activation reducing inflammation Its in vitro activity is often observed in the nanomolar range Typical applications include the use of cell models such as keratinocytes and fibroblasts for inflammatory response assays as well as animal studies to evaluate its therapeutic potential in autoimmune disease models It is also utilized in drug screening to explore effectiveness against chronic inflammatory diseases Experimental concentrations typically depend on the specific research design ensuring precise targeting of the IL-23/Th17 axis for therapeutic exploration

Catalog No. 50-005-68311 Supplier Apexbio Technology LLC Supplier No. F12415
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Anti-IL-23a Antibody (Risankizumab) (CAS No 1612838-76-2) is a monoclonal antibody primarily used in immunology research It targets the p19 subunit of interleukin-23 (IL-23) a cytokine involved in inflammatory pathways pivotal to autoimmune conditions like psoriasis By inhibiting IL-23 Risankizumab modulates the signaling pathway that influences Th17 cell activation reducing inflammation Its in vitro activity is often observed in the nanomolar range Typical applications include the use of cell models such as keratinocytes and fibroblasts for inflammatory response assays as well as animal studies to evaluate its therapeutic potential in autoimmune disease models It is also utilized in drug screening to explore effectiveness against chronic inflammatory diseases Experimental concentrations typically depend on the specific research design ensuring precise targeting of the IL-23/Th17 axis for therapeutic exploration

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.